mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.01 |
mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
GSK429286A |
GDSC1000 |
pan-cancer |
AAC |
-0.094 |
0.02 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.097 |
0.02 |
mRNA |
tosedostat |
CTRPv2 |
pan-cancer |
AAC |
0.094 |
0.02 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
0.093 |
0.02 |
mRNA |
selumetinib:GDC-0941 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.09 |
0.02 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
0.14 |
0.02 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
0.087 |
0.02 |